Ceftazidime/Avibactam (Avycaz) -- a new intraveneous antibiotic.

Found an issue? Give us feedback

The Medical Letter o...arrow_drop_down

The Medical Letter on Drugs and Therapeutics

Article . 2016

Data sources: Europe PubMed Central

Ceftazidime/Avibactam (Avycaz) -- a new intraveneous antibiotic.

descriptionPublicationkeyboard_double_arrow_right Article 29 Apr 2016 English Journal:The Medical letter on drugs and therapeutics, volume 57 (issn: 1523-2859,

Copyright policy )

pmid: 25989198

Ceftazidime/Avibactam (Avycaz) -- a new intraveneous antibiotic.

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Adult, United States Food and Drug Administration, Ceftazidime, United States, Anti-Bacterial Agents, Drug Combinations, Urinary Tract Infections, Humans, Intraabdominal Infections, Administration, Intravenous, beta-Lactamase Inhibitors, Azabicyclo Compounds, Drug Approval

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	6
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%